NuCana plc (NCNA)
NASDAQ: NCNA · Real-Time Price · USD
5.91
-1.11 (-15.81%)
At close: Oct 8, 2025, 4:00 PM EDT
6.08
+0.17 (2.88%)
After-hours: Oct 8, 2025, 7:00 PM EDT
NuCana Market Cap
NuCana has a market cap or net worth of $11.28 million as of October 8, 2025. Its market cap has increased by 54.48% in one year.
Market Cap
11.28M
Enterprise Value
130.28K
1-Year Change
54.48%
Ranking
Category
Stock Price
$5.91
Market Cap Chart
Since September 28, 2017, NuCana's market cap has decreased from $513.70M to $11.28M, a decrease of -97.80%. That is a compound annual growth rate of -37.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 200.00K | -95.74% |
| Dec 31, 2024 | 4.70M | -69.87% |
| Dec 29, 2023 | 15.60M | -54.65% |
| Dec 30, 2022 | 34.40M | -72.30% |
| Dec 31, 2021 | 124.20M | -21.19% |
| Dec 31, 2020 | 157.60M | -19.84% |
| Dec 31, 2019 | 196.60M | -57.38% |
| Dec 31, 2018 | 461.30M | 43.44% |
| Dec 29, 2017 | 321.60M | -37.40% |
| Sep 28, 2017 | 513.70M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 761.35B |
| Johnson & Johnson | 454.62B |
| AbbVie | 407.21B |
| UnitedHealth Group | 333.97B |
| AstraZeneca | 266.44B |
| Novo Nordisk | 261.01B |
| Novartis AG | 255.35B |
| Abbott Laboratories | 231.15B |